Nannan Wu
- Topics
- Bacteriophages and microbial interactions (13 papers)Antibiotic Resistance in Bacteria (6 papers)Genomics and Phylogenetic Studies (4 papers)
- Partner nations
- ChinaFranceUnited States
In The Last Decade
Nannan Wu
44 papers receiving 946 citations
Hit Papers
Peers
Comparison fields: 5 of 110
- Molecular Biology 385
- Ecology 191
- Infectious Diseases 124
- Plant Science 98
- Biomedical Engineering 83
Countries citing papers authored by Nannan Wu
This map shows the geographic impact of Nannan Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nannan Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nannan Wu more than expected).
Fields of papers citing papers by Nannan Wu
This network shows the impact of papers produced by Nannan Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nannan Wu. The network helps show where Nannan Wu may publish in the future.
Co-authorship network of co-authors of Nannan Wu
This figure shows the co-authorship network connecting the top 25 collaborators of Nannan Wu. A scholar is included among the top collaborators of Nannan Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nannan Wu. Nannan Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 1 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 7 | |
| 7 | 19 | |
| 8 | 27 | |
| 9 | 6 | |
| 10 | Regulations of phage therapy across the worldbreakdown → | 82 |
| 11 | 4 | |
| 12 | 18 | |
| 13 | 19 | |
| 14 | 5 | |
| 15 | 5 | |
| 16 | 17 | |
| 17 | 10 | |
| 18 | 54 | |
| 19 | Monoclonal antibody, but not synthetic peptide, targeting the ectodomain of influenza B virus M2 proton channel has antiviral activity. | 4 |
| 20 | 3 |
About Nannan Wu
Nannan Wu is a scholar working on Molecular Medicine, Microbiology and Endocrinology, having authored 48 papers that have together received 954 indexed citations. Recurring topics across this work include Bacteriophages and microbial interactions (13 papers), Antibiotic Resistance in Bacteria (6 papers) and Genomics and Phylogenetic Studies (4 papers). The work is most often cited by research in Molecular Medicine (63 citations), Physiology (52 citations) and Microbiology (59 citations). Nannan Wu has collaborated with scholars based in China, France and United States. Frequent co-authors include Tongyu Zhu, Shuai Le, Chenjiang Ying, Shuiqing He, An‐Dong Gong, Mingyao Liu, Bing Du, Na Zhang, Xuezhi Zuo and Feng Shen. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.